Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Short term Debt: 2022-2024

Historic Short term Debt for Roivant Sciences (ROIV) over the last 3 years, with Mar 2024 value amounting to $12.0 million.

  • Roivant Sciences' Short term Debt fell 72.98% to $12.0 million in Q2 2024 from the same period last year, while for Jun 2024 it was $12.0 million, marking a year-over-year decrease of 72.98%. This contributed to the annual value of $12.0 million for FY2024, which is 70.53% down from last year.
  • Per Roivant Sciences' latest filing, its Short term Debt stood at $12.0 million for FY2024, which was down 73.75% from $45.7 million recorded in FY2023.
  • Roivant Sciences' Short term Debt's 5-year high stood at $45.7 million during FY2023, with a 5-year trough of $12.0 million in FY2024.
  • Moreover, its 3-year median value for Short term Debt was $39.2 million (2022), whereas its average is $34.0 million.
  • In the last 5 years, Roivant Sciences' Short term Debt rose by 21.16% in 2023 and then slumped by 70.53% in 2024.
  • Over the past 3 years, Roivant Sciences' Short term Debt (Yearly) stood at $37.7 million in 2022, then reached $40.7 million in 2023, then grew by 21.16% to $45.7 million in 2023, then tumbled by 70.53% to $12.0 million in 2024.